loadpatents
Patent applications and USPTO patent grants for YOKOTA; Toshifumi.The latest application filed is for "exons 45-55 skipping using mutation-tailored cocktails of antisense morpholinos in the dmd gene".
Patent | Date |
---|---|
Exons 45-55 Skipping Using Mutation-tailored Cocktails Of Antisense Morpholinos In The Dmd Gene App 20220288218 - YOKOTA; Toshifumi ;   et al. | 2022-09-15 |
Antisense Oligonucleotides That Bind To Exon 51 Of Human Dystrophin Pre-mrna App 20210395741 - YOKOTA; Toshifumi ;   et al. | 2021-12-23 |
Antisense oligonucleotides that bind to exon 51 of human dystrophin pre-mRNA Grant 11,142,767 - Yokota , et al. October 12, 2 | 2021-10-12 |
Antisense Oligonucleotides That Bind To Exon 51 Of Human Dystrophin Pre-mrna App 20200362336 - Yokota; Toshifumi ;   et al. | 2020-11-19 |
Gapmers And Methods Of Using The Same For The Treatment Of Muscular Dystrophy App 20200291398 - CHEN; Yi-wen ;   et al. | 2020-09-17 |
Information processing system Grant 5,864,335 - Kuzunuki , et al. January 26, 1 | 1999-01-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.